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Background: Cancer and HIV/AIDS are two of the greatest public health and humanitarian challenges facing the
world today. Infection with HIV not only weakens the immune system leading to AIDS and increasing the risk of
opportunistic infections, but also increases the risk of several types of cancer. The enormous biodiversity of marine
habitats is mirrored by the molecular diversity of secondary metabolites found in marine animals, plants and
microbes which is why this work was designed to assess the anti-HIV and cytotoxic activities of some marine
organisms of the Red Sea.
Methods: The lipophilic fractions of methanolic extracts of thirteen marine organisms collected from the Red Sea
(Egypt) were screened for cytotoxicity against two human cancer cell lines; leukaemia (U937) and cervical cancer
(HeLa) cells. African green monkey kidney cells (Vero) were used as normal non-malignant control cells. The extracts
were also tested for their inhibitory activity against HIV-1 enzymes, reverse transcriptase (RT) and protease (PR).
Results: Cytotoxicity results showed strong activity of the Cnidarian Litophyton arboreum against U-937
(IC50; 6.5 μg/ml ±2.3) with a selectivity index (SI) of 6.45, while the Cnidarian Sarcophyton trochliophorum showed
strong activity against HeLa cells (IC50; 5.2 μg/ml ±1.2) with an SI of 2.09. Other species showed moderate to
weak cytotoxicity against both cell lines. Two extracts showed potent inhibitory activity against HIV-1 protease;
these were the Cnidarian jelly fish Cassiopia andromeda (IC50; 0.84 μg/ml ±0.05) and the red algae Galaxura filamentosa
(2.6 μg/ml ±1.29). It is interesting to note that the most active extracts against HIV-1 PR, C. andromeda and
G. filamentosa showed no cytotoxicity in the three cell lines at the highest concentration tested (100 μg/ml).
Conclusion: The strong cytotoxicity of the soft corals L. arboreum and S. trochliophorum as well as the anti-PR
activity of the jelly fish C. andromeda and the red algae G. filamentosa suggests the medicinal potential of crude
extracts of these marine organisms.
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Life-threatening illnesses such as cancer and the ac-
quired immunodeficiency syndrome (AIDS) presents pa-
tients and their families with considerable burdens. For
many sufferers both cancer and AIDS have evolved from
acutely terminal conditions into chronic illnesses charac-
terized by complex psychosocial and physical issues.
The number of people living with HIV/AIDS in 2010
was estimated to be around 34 million [1]. On the other
hand a total of 1,638,910 new cancer cases and 577,190
deaths from cancer were determined to have occurred in* Correspondence: Debra.Meyer@up.ac.za
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reproduction in any medium, provided the orthe United States in 2012 [2]. Lower CD4 (white blood
cell) counts and a weakened immune system are risk fac-
tors for pre-cervical and cervical cancer. Additionally,
women with HIV are more likely to have a recurrence of
pre-cervical cancer and antiretroviral therapy did not
protect HIV-positive women from the development of
pre-cervical cancer [3-5].
In order to combat both cancer and HIV/AIDS, colos-
sal amounts of money, manpower, time and energy have
been dedicated to research on novel compounds which
can be developed as therapeutic agents [2]. Anti-cancer
drugs and HIV treatment are related since nucleotide
analogues can be used for the treatment of both dis-
eases. Using natural products to manufacture drugs is anLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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miliar products such as morphine, digitalis, penicillin,
and aspirin [6].
Mankind has known for thousands of years that mar-
ine organisms contain substances capable of potent
biological activity which has recently also been demon-
strated against different types of cancer and HIV/AIDS
[7]. Natural product screening has been a component
of drug-lead development for the better part of 20 years.
Novel pharmaceuticals, such as taxol, have been discov-
ered through the screening of extracts from plants, mi-
croorganisms and marine organisms [8], while in vitro
inhibition of key enzymes of the viral life cycle serves as a
first step in HIV/AIDS drug development.
The studies on the antiviral activities of marine natural
products are presently attracting more and more atten-
tion worldwide. Marine derived compounds have been
shown to have a variety of bioactivities such as antiviral,
anticoagulant, antioxidant and other medicinal proper-
ties [9]. HIV-1 enzymes RT and PR were identified early
on as potential drug targets. The discovery and develop-
ment of inhibitors of these enzymes are an unqualified
success of modern pharmacology and structural biology
[10]. The emergence of drug-induced mutations of HIV-
1 enzymes leads to rapid loss of the potency of existing
drugs and the need to develop new candidates [11].
The Red sea represents one of the most promising areas
as a source of medicinal natural products. Most of the in-
vestigations into the biological activities of organisms from
the Red Sea was conducted either in the northern part of
gulf Aqaba [12,13] or the southern part of the sea and
reported on the organisms’ free radical scavenging and
cancer growth inhibition activities [14-16]. These areas
are subject to tourism and human impact, which can ex-
tensively affect the marine community. As reported by
“Zalul,” an Israeli environmental lobby group, ‘over the
past five years the most northerly part of the Red Sea coral
reef is now 70% dead’ [17].
The study area investigated in the current report,
Sharm El-Sheikh, is located in the connection point of
the south Suez Gulf and south Aqaba Gulf. Most of this
region is protected by the Egyptian Ministry of State For
Environmental Affairs. Despite its high water quality, there
are no published reports for the biological activities of
marine organisms from Sharm El-Sheikh which prompted
the present investigation.
This study was designed to investigate the potential
cytotoxic and anti-HIV activities of thirteen marine organ-
isms collected from Sharm El-Sheikh, Red Sea (Egypt).
Methods
Marine organisms
Thirteen of the most abundant marine organisms from
different families were collected from Nabq and RasMohammed protected areas (Sharm el-Sheikh, Red Sea,
Egypt) in the period between March and April 2010.
Fifty gram (50 g) of each sample was collected according
to the sampling and preservation protocol of Kathrina
Fabricius [18]. The material was collected and identified
by Mona Ellithey, co-author of this article, using Red
sea invertebrates’ reference guide [19] which also pro-
vided detailed information specimen classification as
indicated per organism below. A voucher specimen has
been deposited in the Marine Natural products labo-
ratory, NRC (Egypt) with deposition number 10/1:13.
Samples were collected from different marine environ-
ments. Two sponges; Spongia officinalis (Linnaeus, 1759),
Haliclona rubens (sensu Duchassaing & Michelotti, 1864)
and the jelly fish Cassiopea andromeda (Forskål, 1775) were
collected from 0.6-1 m depth of mangrove swamps. The
sandy bottom was used for collection of the algae Cymo-
docea rotundata (Ehrenberg & Hemprich ex Ascherson
1870), Caulerpa prolifera (Forsskål J.V. Lamouroux 1809)
and the gastropod Bulla ampulla (Linnaeus, 1758), from
depths of 30-60 cm. From the stony bottom of the coral
reef the algae Galaxaura filamentosa (W.R. Taylor 1945),
the soft corals Litophyton arboreum (Forskål, 1775), Sarco-
phyton trochliophorum (Von Marenzeller, 1886), Sinularia
heterospiculata, Sinularia maxima, Sinularia polydactyla
(Verseveldt, J. 1976) and Turbinaria turbinatea (Linnaeus
Kuntze 1898) were collected at depths of 1-3 m.
Extract preparation
Fresh marine organisms (50 g each) were homogenized
directly after collection with 150 ml of 90% methanol
(Merck, Germany). After filtration the solvent was evap-
orated under reduced pressure using a rotary evaporator
(Buchi, Switzerland) and the residues re-suspended in
water and partitioned with ethyl acetate in order to get
rid of the salts and the high molecular weight hydro-
philic compounds. The lipophilic fractions obtained by
ethyl acetate were dried out by rotavapor and were then
tested for their in vitro cytotoxicity against two human
cancer cell lines (U937) and (HeLa), and the African
green monkey kidney cell line (Vero) as representative
of a normal, non-cancerous cell line. The extracts were
also tested for inhibitory activity in direct enzyme assays
against HIV-1 reverse transcriptase and HIV-1 protease.
Cell culture and cytotoxicity of extracts
Chemicals and reagents; all cell lines, media, trypsin-
EDTA, fetal bovine serum (FBS) and antibiotics (penicillin,
streptomycin and fungizone) were purchased from High-
veld Biological (Pty) Ltd. (Modderfontein, Johannesburg,
RSA).
The ethyl acetate extracts were each dissolved in
DMSO to a stock solution of 20 mg/mL and added to
the microtitre plate. Serial dilutions were made to range
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each extract. The negative control wells included cells ex-
posed to 2% DMSO. And the positive control Actinomy-
cin D with concentrations ranging between 0.5 μg/mL and
0.002 μg/mL. The microtitre plate was incubated for a fur-
ther 72 h. and were tested for their cytotoxic activity using
the 2,3-bis-(2-methoxy-4-nitro- 5-sulfophenyl)-2H-tetra-
zolium-5-carboxanilide, Na2) (XTT) colorimetric assay.
The assay is based on the ability of live cells to reduce the
yellow water soluble XTT into an insoluble formazan
product [20]. The marine extracts were first screened for
their in vitro cytotoxicity at a concentration of 100 μg/ml
against HeLa and U937 cells. Extracts which reduced >
50% of the cell proliferation of both cell lines were further
tested at concentrations that ranged from (400 μg/ml to
3.12 μg/ml). A third non-cancerous cell line (Vero) was
also included for the most active extracts in order to de-
termine selectivity indices which represent the overall ac-
tivity of the extract. Selectivity Indexes (SI) values were
calculated as follows; the 50% inhibitory concentration
(IC50) of the extract tested in Vero cell line was divided by
the IC50 of the extract tested in a cancer cell. Higher SI
values indicate the more selective extracts.
Cells were maintained in culture flasks in complete
medium supplemented with 10% heat-inactivated FBS and
antibiotic cocktail (100 U/mL penicillin, 100 g/L strepto-
mycin and 250 g/L fungizone). Cells were cultured and
maintained in a humidified atmosphere at 37°C and 5%
CO2. Cytotoxicity was measured by the XTT method
using the Cell Proliferation Kit II (F. Hoffmann-La Roche
Ltd.). Cells (100 μl) were seeded (concentration 1 × 105
cells/mL) into a microtitre plate and incubated for 24 h to
allow the cells to adhere. Following the evaporation of
ethyl acetate, the extract powder residue was dissolved in
DMSO and then serially diluted (400 μg/ml to 3.12),
added to the plates and incubated for 72 h. A positive con-
trol for cytotoxicity, actinomycin D and a negative control
of cells with 2% DMSO were also included. After a 72 h
incubation, XTT was added to a final concentration of
0.3 mg/mL and the cells incubated for 2–3 h. Absorbance
of the developed colour was spectrophotometrically de-
termined using a multi-well plate reader which mea-
sured the optical density at 450 nm with a reference
wavelength of 690 nm. Mean IC50 is the concentration
of extracts which reduces cell growth by 50% under the
experimental conditions and is the average of at least
three independent reproducible measurements. The
IC50 values were performed using GraphPad Prism (San
Diego, USA).
HIV-1 direct enzyme assays
Reverse transcriptase (RT) inhibitory activity of the crude
extracts against a purified recombinant HIV1-RT (Merck,
Darmstadt, Germany) was determined by using the RocheDiagnostics (Mannheim, Germany) colorimtric kit. The
assay was performed as previously described [21].
HIV-1 protease enzyme (Bachem Bioscience Inc. King
of Prussia, PA, UK) and the substrate (a synthetic peptide
that contains a cleavage site Tyr-Pro for HIV protease as
well as two covalently modified amino acids for the de-
tection of cleavage). The assay was performed according
to procedures by Lam et al. [22] in black 96 well assay
plates obtained from Corning Incorporated, (Corning,
New York, USA). The fluorescence intensity was measured
at an excitation wavelength of 355 nm and an emission
wavelength of 460 nm using a synergy microplate spec-
trofluorometer (BioTek, Analytical & Diagnostic products,
South Africa). Acetyl pepstatin (AP) was used as a positive
control for HIV-1 PR inhibition. The blank treatment
consisted of assay buffer with only the substrate and an un-
treated control of enzyme and substrate was also included.
The percentage inhibition was calculated based on the
formula:
100–½ Test reagent RFU–background RFUð Þ=
untreated control RFU–blankð Þ  100
where RFU = relative fluorescence units.
All the marine organism materials were screened at
100 μg/ml for inhibition of HIV-1 enzymes. IC50 values
of the most active extracts were calculated and com-
pared to known HIV-1 PR and HIV-1 RT inhibitors. All
the experiments were done 3 times in order to ensure
the precision and accuracy of the data.
Statistical analysis
One way ANOVA analysis was done followed by post
hoc Tukey HSD tests to determine the significance of
the extracts’ cytotoxicity and inhibitory activities. The
statistical analysis was done using IBM SPSS version 19.
Results and discussion
Cytotoxicity of the extracts
The cytotoxicity of the soft corals L. arboreum, S. polydac-
tyla, S. maxima and S. heterospiculata were tested for the
first time in U937 cells. In Figure 1 the cytotoxicity of ex-
tracts at 100 μg/ml is shown, indicating that these soft
corals demonstrated potent cytotoxicity by killing more
than 90% of the cells. Extracts of the mentioned organisms
were significantly different (P < 0.000) from the values for
negative controls (see Figure 1).
Moderate cytotoxicity (<60% of cell death) was demon-
strated by the soft coral S. trocheliophorum, the green
algae C. prolifera, the sponges S. officinalis and H. rubens,
the sea grass C. rondata and the brown algae T. turbinata.
The lowest cytotoxicity in U937 cells was observed from
the mollusc B. ampulla, the jelly fish C. andromeda and
Figure 1 Cytotoxicity of different marine extracts. Samples were dissolved in DMSO and diluted with the medium to a final concentration of
100 μg/ml. Significant differences between the extracts and the DMSO control was calculated using IBM SPPS version 19. **P < 0.00, *P < 0.05 and
N indicates not significant.
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still viable.
This is also the first report for the cytotoxicity of the
mollusc B. ampulla and the soft coral S. polydactyla in
HeLa cells. As shown in Figure 1, these organisms
showed potent cytotoxicity by killing more than 90% of
the cells when tested at 100 μg/ml. The soft corals L.
arboreum, S. maxima and S. trocheliophorum showed
strong cytotoxicity and killed more than 80% of the cells.
C. prolifera and S. heterospiculata showed moderate
toxicity (<60%). The lowest cytotoxicity in HeLa cells was
observed for S. officinalis, T. turbinata, C. andromeda,
H. rubens and C rotundata where more than 60% of the
cells were still viable.
Following these observations only potent and the strongly
active extracts were subjected to detailed study to deter-
mine their half maximal inhibitory concentrations (IC50)
and selectivity indices. Once the IC50 values were deter-
mined, responses of the marine extracts were character-
ized according to the guidelines of the National Cancer
Institute (NCI) where IC50 values of 10-20 μg/ml of a
total/crude extract is viewed as cytotoxic, 20 ≤ 50 μg/ml
as moderately cytotoxic and < 10 μg/ml as strongly cyto-
toxic. As the selectivity index value of an extract in-
crease the ability of the extract to target the cancer cells
rather than normal body cells also increases.
As shown in Table 1, the soft coral L. arboreum pre-
sented very strong cytotoxicity and selectivity (IC50; 6.5 μg/
ml, SI; 6.45) in U937 cells which is reported here for the
first time. It also showed a moderate activity in HeLa (IC50;
28.10 μg/ml, SI; 1.46) as compared to the cytotoxicity
positive control, Actinomycin D (IC50 7.8 μg/ml, SI 1.5)
in U937 cells and (IC50; 17.7 μg/ml, SI; 1.5) in HeLa.
The observed toxicity can be due to the terpenoidswhich are extensively reported in soft corals from the
family Alcyoniidae [23]. Terpenoids, mainly macrocyclic
cembrane-type diterpenoids and their derivatives, repre-
sent important chemical defense tools for these animals
against their natural predators [24]. Results presented here
are supported by current literature reporting that L. arbor-
eum demonstrated moderate cytotoxicity against HUVEC,
K-562 and HeLa [25], L-929 and K-562 [26] as well as
strong antibacterial activity [27].
The soft coral, Sarcophyton trocheliophorum showed
promising cytotoxicity with a selectivity index higher than
the positive control (IC50 5.2 μg/ml, SI; 2) in HeLa cells. In
a similar study polyhydroxy sterols from S. trochelio-
phorum obtained in Singapore showed potent cell growth
inhibitory activity against different human HL60 leukae-
mia (the present study used U937), M14 skin melanoma,
and MCF7 breast carcinoma cells with EC50 values of 2.8,
4.3, and 4.9 μg/ml respectively detected by the MTT assay
(a related, not identical tetrazolium dye was used here),
and exhibited minimal toxicity to normal human periph-
eral blood lymphocytes [28]. These data suggests that
S. trocheliophorum from any marine environment may be
producing sterols which when isolated or present in an
extract retain their potency and may yet prove useful as
anti-cancer drugs.
Previous studies showed that a hybridization of Sinu-
laria polydactyla and Sinularia maxima species had
strong cytotoxicity in the following cell lines; the breast
cancer SK-BR3 cell line, cervical cell line, HeLa and
HeLa-Apl cell lines [29]. In the current study, when the
original organisms (not hybrids) were tested, S. polydac-
tyla exhibited moderate cytotoxicity (IC50; 20 μg/ml, SI;
0.34) in HeLa cells. S. maxima had moderate toxicity
(IC50; 24.0 μg/ml, SI; 1.8) in U937 and in HeLa cells
Table 1 The half maximal inhibition concentration (IC50) of the lipophilic fraction of the marine organism extracts
against HIV-1 PR is presented
Phylum Marine
organism
Cytotoxicity IC50 (μg/mL) SI values IC50 (μg/mL)
U937 HeLa Vero U937 HeLa HIV-1 PR
Mollusca B. ampulla N/Ta 76.53 110.80 N/A 1.4 N/Tb
Rhodophyta G. filamentosa N/Ta N/Ta N/Ta N/A N/A 2.6
Chlorophyta C. prolifera 52.46 32.32 143.21 2.73 4.43 N/Tb
Phaeophyta T. turbinatea N/Ta N/Ta N/Ta N/A N/A N/Tb
Tracheophyta C. rotundata N/Ta N/Ta N/Ta N/A N/A N/Tb
Porifera H. rubens N/Ta N/Ta N/Ta N/A N/A N/Tb
Porifera S. officinalis N/Ta N/Ta N/Ta N/A N/A N/Tb
Cnidaria C. andromeda N/Ta N/Ta N/Ta N/A N/A 0.84
Cnidaria S. heterospiculata 44.54 n/a 43.95 0.99 n/a 8.6
Cnidaria S. maxima 24.00 30.08 43.95 1.83 1.46 13.1
Cnidaria S. polydactyla 89.05 20.0 6.80 0.08 0.34 N/Tb
Cnidaria L. arboreum 6.50 28.10 41.90 6.45 1.46 12.0
Cnidaria S. trocheliophorum N/Ta 5.200 10.90 N/A 2.10 N/Tb
Actinomycin Dc 7.8 17.7 11.8 1.5 0.7 N/Tb
Acetylpepstatind 5.7
The IC50 values were determined in different cell lines and are presented along with the associated selectivity index (SI) values which represent the relative
activity towards the cancer cell lines compared to the Vero cells.
Not tested (N/Ta) samples with inhibitory activities less than 50% at 100 μg/ml.
Not tested (N/Tb) samples with inhibitory activities less than 80% at 100 μg/ml.
Superscript C indicates the anticancer drug used as positive control for the cytotoxicity assay.
Superscript D indicates the positive control used in the PR inhibition assay.
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that is reported here for the first time, S. heterospiculata,
exhibited low cytotoxicity (IC50; 44.5 μg/ml, SI; 0.99) in
U937 and no activity in HeLa cells.
The green algae C. prolifera showed weak to moderate
cytotoxicity in U937 and HeLa cell lines (IC50; 52.46 μg/ml,
32.3 μg/ml and SI; 2.73, 4.4) respectively. Caulerpenyne
(Cau), a metabolite from Caulerpa taxifolia has previously
been shown to be cytotoxic against KB cells and fibro-
blasts from hamsters. Cau along with 6 other drugs rep-
resentative of the major classes of anticancer products
were tested against 8 cancer cell lines of human origin.
Cau demonstrated growth-inhibitory effects in all cases
with some variability between cell lines. It was also shown
to induce inhibition of SK-N-SH tumour cell proliferation
with an IC50 of 10 +/- 2 micro M [30-32]. It is there for
possible that the cytoxicity demonstrated by the crude
extract of C.prolifera, may increase if compounds like Cau
is isolated from it. All other tested species showed moder-
ate to weak activity against both cell lines.
The main goal of cancer chemotherapy research is to
discover safe and efficient agents that target cancer cells
specifically but are innocuous to normal cells. However,
many anticancer drugs fail to meet this criterion being
unable to discriminate between cancer and normal cells.
The development of novel cancer chemotherapeutic
agents with a higher potency and specificity againstcancer cells is urgently needed. The selectivity index of
L. arboreum in U937 and S. trocheliophorum in HeLa
compares very well and even better than the positive
control used in this study and is worthy of further
investigation.
Anti-HIV direct enzymes assays
All the extracts were tested at 100 μg/ml for the inhib-
ition of HIV-1 RT and PR enzymes. The experiment was
repeated at least 3 times. Extracts with percentages of
inhibition ≥ 50% were considered to be active while the
extracts demonstrating >90% inhibition were considered
potent.
Unfortunately, none of the screened extracts showed
any inhibitory activity of HIV-1 RT (all inhibitions were
< 50%). In cases where marine organisms were able to
inhibit this enzyme, it was always pure compounds
which were hydrophilic in nature, suggesting that for ac-
tivity against this enzyme, more aqueous extracts should
be prepared [33]. On the other hand most of the extracts
inhibited HIV-1 PR enzyme in the direct assays. These
data is presented in Figure 2 demonstrating that strong
inhibitory activity (>80%) were obtained by S. maxima,
L. arboreum, B. ampulla, C. andromeda, G. filamentosa,
and S. heterospiculata. Values of these active extracts
were significantly different (P < 0.00) from the values for
negative controls (See Figure 2). S. trocheliophorum and
Figure 2 HIV-1 PR inhibition percentages of different marine extracts. Samples were dissolved in DMSO and diluted with the assay buffer to
a final concentration of 100 μg/ml. Significant differences between the extracts and the DMSO control was calculated using IBM SPPS version 19.
**P < 0.00, *P < 0.05 and N indicates not significant. AP indicates the experimental positive control acetyl pepstatin.
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strating inhibitory activities of 65-80%. C rotundata and
C. prolifera exhibited very weak inhibitory activity (< 50%).
Only the extracts with strong inhibitory activity were
subjected to detailed study using serial dilutions of each
extract in order to determine their IC50 values. Following
IC50 assessments, the extract activities were classified as
follows; potent activities were assigned to IC50 < 10 μg/ml,
while IC50 10 < 20 μg/ml was considered strong, and IC50
20 < 50 μg/ml as moderate. Extracts demonstrating IC50
values of > 50 μg/ml were considered weak.
The detailed IC50 study showed potent inhibitory activ-
ity of HIV-1 PR by the Cnidarian jelly fish C. andromeda
(IC50 0.84 μg/ml). Phylum Cnidaria was reported to have
antimicrobial [34], antioxidant [35] and anti-inflammatory
[36] activities. Nothing has been reported on the anti
HIV-1 or the cytotoxicity of C. andromeda until now.
In this study, the red algae G. filamentosa showed po-
tent HIV-1 PR inhibitory activity (IC50 2.6 μg/ml). Many
studies have discussed the biological importance of mar-
ine algae. Some of the studies in search of anti-herpetic
substances have been particularly interesting. The use of
these organisms as botanical agents to treat viral infec-
tion resulted in four patents [37-39]. The first two pat-
ents used aqueous extracts of Neodilsea americana and
N. integra [40] while the third patent is particularly well
documented and involves the use of Cryptosiphonia woo-
dii [41]. For the latter, clinical efficacy was clearly demon-
strated. The fourth patent is for the use of carrageenan
and other sulfated polysaccharides for the treatment of
diseases (including AIDS) caused by retroviral infection
[42]. In another study on the hydrophilic metabolites (sul-
fated oligo- or poly-saccharide compounds) from redalgae, retroviral replication was suppressed and viral
reverse transcriptase inhibited [33].
It is important to mention that our study is the first
report of the promising HIV-1 protease inhibitory activ-
ity of C. andromeda (IC50; 0.84) μg/ml and G. filamen-
tosa (IC50; 2.6 μg/ml) while the IC50 of the positive
control (acetyl pepstatin) for enzyme inhibition in the
assay was 5.7 μg/ml. These extracts showed no cytotox-
icity against the three cell lines at the highest concentra-
tion (100 μg/ml) tested.
Moderate HIV-1 PR inhibitory activities were shown
by the soft corals S. heterospiculata (8.6 μg/ml ±3.4), L.
arboreum (12.007 μg/ml ±2.4) and S. maxima (13.1 μg/ml ±
2.3). Metabolites from soft corals found to have cy-
totoxicity against selected cancer cell lines, antiviral
activity against human cytomegalo virus (HCMV), anti-
inflammatory activity and antibacterial activity against
five selected bacterial strains, have been reported [43].
To date, no anti-HIV activity have been reported in litera-
ture for the three soft corals tested here. Enzymatic assays
are an important first step when identifying potential anti-
HIV leads, however screening extracts and especially pure
compounds in virus infected cell cultures are essential
next steps to ensure that only the most promising of com-
pounds able to inhibit whole virus replication progresses
in the drug development pipe line.
Conclusion
The present study demonstrated that marine organisms
remain one of the most interesting sources for the discov-
ery of bioactive leads that can help in the treatment of
cancer and HIV. This study is the first to report the anti-
cancer and anti HIV activities of B. ampulla, C. rotundata,
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rospiculata, S. officinalis and T. turbinata. This is also
the first report on the HIV-1 PR inhibitory activities of
extracts of C. andromeda, C. prolifera and L. arboreum,
S. maxima, S. polydactyla.
Although the cytotoxicity of some of the extracts re-
ported on here, have previously been tested in the HeLa
cell line (for C. prolifera, L. arboreum, S. maxima and S.
polydactyla), this study is the first to report cytotoxicity
of these extracts in a leukaemia cancer cell line (U937).
The bio-activity evaluation of the extracts resulted in
two marine extracts demonstrating strong anticancer ac-
tivity; L. arboreum in U937 cells and S. trochliophorum
in HeLa with high safety margins compared to Actino-
mycin D. C. andromeda showed potent anti-PR activity
with an IC50 6 times lower than the positive control with
no cytotoxicity in the different cell lines while G. fila-
mentosa extract showed double the activity of the posi-
tive control with higher safety margins. These findings
suggest that these species could be an interesting source
of bioactive compounds and deserve further bioassay-
guided isolation procedures to determine the identity
and structure of the active compounds.
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